熱門資訊> 正文
MDR, GPS among premarket losers
2019-11-08 22:10
- Agios製藥(AGIO) 0
- 快驗保(MED) 0
- 天睿公司(TDC) 0
AnaptysBio (NASDAQ:ANAB) -73% after Q3 results and lead drug flunks dermatitis study.
Therapix Biosciences (NASDAQ:TRPX) -40% on mutual decision with Destiny Biosciences Global to discontinue negotiations on the previously announced proposed merger.
Red Lion Hotels (NYSE:RLH) -34% after Q3 results.
Medifast (NYSE:MED) -32% after Q3 results.
Teradata (NYSE:TDC) -25% after Q3 results.
Green Dot (NYSE:GDOT) -18% after Q3 results.
McDermott International (NYSE:MDR) -14%.
Affimed N.V. (NASDAQ:AFMD) -11% after pricing stock offering.
Bionano Genomics (NASDAQ:BNGO) -11% after Q3 results.
Turtle Beach (NASDAQ:HEAR) -9% after Q3 results.
The Gap (NYSE:GPS) -8% after slashing guidance and CEO exit.
Agios Pharmaceuticals (NASDAQ:AGIO) -6% on pricing of $256M equity offering..
